Loading clinical trials...
Loading clinical trials...
LCCC 1210 - Phase II, Multicenter, Single Arm Study of the Tolerability of Weekly Nab-paclitaxel as Second Line Treatment for Elderly Patients With Advanced Lung Cancer
Conditions
Interventions
Nab-Paclitaxel
Locations
8
United States
Highlands Oncology Group
Fayetteville, Arkansas, United States
UNC Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
Rex Healthcare
Raleigh, North Carolina, United States
Cleveland Clinic
Cleveland, Ohio, United States
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Start Date
June 25, 2013
Primary Completion Date
June 23, 2017
Completion Date
July 12, 2019
Last Updated
October 8, 2020
NCT07259226
NCT05473156
NCT06889467
NCT07283198
NCT04772989
NCT01970865
Lead Sponsor
UNC Lineberger Comprehensive Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions